Occult HCV infection: An unexpected finding in a population unselected for hepatic disease

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  de Marco, Laura ^a   Gillio Tos, Anna ^a   Fiano, Valentina ^a   Ronco, Guglielmo ^a   Krogh, Vittorio ^b   Palli, Domenico ^c   Panico, Salvatore ^d   Tumino, Rosario ^e   Vineis, Paolo ^a   Merletti, Franco ^a   Richiardi, Lorenzo ^a   Sacerdote, Carlotta ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e CIVILE M P AREZZO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; VIRUS RNA;

5' UNTRANSLATED REGION; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLADDER CANCER; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; UTERINE CERVIX CANCER;

ADULT; AGED; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED;

HEPATITIS C VIRUS;

EID: 77953974754     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008128     Document Type: Article

References (38)

1. Castillo I, Pardo M, Bartolomé J, Ortiz-Movilla N, Rodríguez-Iñigo E, et al. (2004) Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 189: 7-14.
2. Castillo I, Rodríguez-Iñigo E, Bartolomé J, de Lucas S, Ortíz-Movilla N, et al. (2005) Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut 54: 682-685.
3. Pardo M, López-Alcorocho JM, Rodríguez-Iñigo E, Castillo I, Carreño V (2007) Comparative study between occult hepatitis C virus infection and chronic hepatitis C. J Viral Hepat 14: 36-40.
4. Carreño V (2006) Occult hepatitis C virus infection: a new form of hepatitis C. World J Gastroenterol 12: 6922-6925.
5. Welker MW, Zeuzem S (2009) Occult hepatitis C: how convincing are the current data? Hepatology 49: 665-675.
6. Pham TNQ, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, et al. (2004) Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78: 5867-5874.
7. Carreño V, Bartolomè J, Castillo I, Quiroga JA (2008) Occult hepatitis B virus and hepatitis C virus infections. Rev Med Virol 18: 139-157.
8. Radkowski M, Horban A, Gallegos-Orozco JF, Pawelczyk A, Jablonska J, et al. (2005) Evidence for viral persistence in patients who test positive for anti- hepatitis C virus antibodies and have normal alanine aminotransferase levels. J Infect Dis 191: 1730-1733.
9. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, et al. (2005) Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41: 106-114.
10. Casato M, Lilli D, Donato G, Granata M, Conti V, et al. (2003) Occult hepatitis C virus infection in type II mixed cryoglobulinaemia. J Viral Hepat 10: 455-459.
11. Giannini C, Giannelli F, Zignego AL (2006) Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment. Hepatology 43: 1166-1167.
12. Berasain C, Betés M, Panizo A, Ruiz J, Herrero JI, et al. (2000) Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. GUT 47: 429-435.
13. Pham TNQ, Mercer SE, Michalak TI (2009) Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles. J Viral Hepat 16: 547-556.
14. Chang TT, Young KC, Yang YS, Lei HY, Wu HL (1996) Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection. Hepatology 23: 977-981.
15. Lerat H, Hollinger FB (2004) Hepatitis C virus (HCV) occult infection or occult HCV-RNA detection? J Infect Dis 189: 3-6.
16. Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J (2002) The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus. J Infect Dis 185: 417-421.
17. Féray C, Samuel D, Thiers V, Gigou M, Pichon F, et al. (1992) Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 89: 1361-1365.
18. Pham TNQ, Michalak TI (2008) Occult persistence and lymphotropism of hepatitis C virus infection. World J Gastroenterol 14: 2789-2793.
19. Pham TNQ, King D, Macparland SA, McGrath JS, Reddy SB, et al. (2008) Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and Occult Infection. Gastroenterology 134: 812-822.
20. Clarke B (1997) Molecular virology of hepatitis C virus. J Gen Virol 78: 2397-2410.
21. Pardo M, López-Alcorocho JM, Castillo I, Rodríguez-Iñigo E, Perez-Mota A, et al. (2006) Effect of anti-viral therapy for occult hepatitis C virus infection. Aliment Pharmacol Ther 23: 1153-1159.
22. Palli D, Krogh V, Russo A, Berrino F, Panico S, et al. (1999) EPIC-Italy. A molecular epidemiology project on diet and cancer. Adv Exp Med Biol 472: 21-28.
23. Palli D, Berrino F, Vineis P, Tumino R, Panico S, et al. (2003) EPIC-Italy. A molecular epidemiology project on diet and cancer: the EPIC-Italy Prospective Study. Design and baseline characteristics of participants. Tumori 89: 586-593.
24. Feld JJ, Liang TJ (2005) HCV persistence: cure is still a four letter word. Hepatology 41: 23-25.
25. Comar M, Dal Molin G, D'Agaro P, Crocè SL, Tribelli C, et al. (2006) HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers. J Clin Pathol 59: 526-529.
26. Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, et al. (2005) Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 76: 327-332.
27. Barril G, Castillo I, Arenas MD, Espinosa M, Garcia-Valdecasas J, et al. (2008) Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol 19: 2288-2292.
28. Sharma AD, Sreeram G, Erb T, Grocott HP, Slaughter TF (2000) Leukocyte- reduced blood transfusions: perioperative indications, adverse effects, and cost analysis. Anesth Analg 90: 1315-1323.
29. Murphy MF (1999) New variant Creutzfeldt-Jakob disease (nvCJD): the risk of transmission by blood transfusion and the potential benefit of leukocyte- reduction of blood components. Transfus Med Rev 13: 75-83.
30. Kopko PM, Holland PV (2000) Universal leukocyte reduction. Curr Opin Hematol 7: 397-401.
31. Guidelines for UK transfusion services (2005) 7th edn. London: The Stationary Office.
32. Gordon SC (2005) Occult viral hepatitis and noncirrhotic hepatocellular carcinoma. Am J Gastroenterol 100: 1754-7.
33. Pardo M, López-Alcorocho JM, Castillo I, Rodríguez-Iñigo E, Quiroga JA, et al. (2007) Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol 81: 7710-7715.
34. Sacerdote C, Matullo G, Polidoro S, Gamberini S, Piazza A, et al. (2007) Intake of fruits and vegetables and polymorphisms in DNA repair genes in bladder cancer. Mutagenesis 22: 281-285.
35. Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, et al. (2006) Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 98: 765-774.
36. Colin C, Lanoir D, Touzet S, Meyaud-Kraemer L, Bailly F, et al. (2001) Sensitivity and specificity of third generation hepatitis C virus antibody detection assays: an analysis of the literature. J Viral Hepat 8: 87-95.
37. Lossos IS, Czerwinski DK, Wechser MA, Levy R (2003) Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. Leukemia 17: 789-795.
38. Cuypers HT, Bresters D, Winkel IN, Reesink HW, Weiner AJ, et al. (1992) Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Microbiol 30: 3220-3224.